EssilorLuxottica Société anonyme against Moderna, Inc. — live side-by-side technical comparison.
Prices as of 2026-10-13T15:36:08+00:00 UTC · updates daily
MRNA leads 5 of the 5 windows we measure — over 1 month EL.PA is -0.1% and MRNA +50.2%; over year to date EL.PA is -45.8% and MRNA +633.3%.
| EL.PA | MRNA | |
|---|---|---|
| Price | $146.30 | $216.25 |
| 1 day | -0.3% | +1.2%lead |
| 5 days | -0.3% | +15.4%lead |
| 1 month | -0.1% | +50.2%lead |
| 6 months | -25.8% | +326.7%lead |
| Year to date | -45.8% | +633.3%lead |
| 52-week position | 4% of range | 95% of range |
| 52-week range | $138.30–$323.80 | $22.28–$227.46 |
| vs 50-day average | below $153.32 | above $144.66 |
| vs 200-day average | below $190.72 | above $74.46 |
| RSI (14) | 43 | 64 |
| Next earnings | 2026-02-11 | 2026-11-06 |
EL.PA trades at $146.30, below its 50-day average of $153.32, and below the 200-day at $190.72. It sits at 4% of its 52-week range ($138.30–$323.80); 14-day RSI is 43, in neutral territory; an average session moves it about 2.8%. For levels, the first level overhead is $150.00 (2.5% away) and the first support below is $139.00 (5.0% down). On the checklist the page runs for every asset, 1 of 6 checks read bullish — the lean is bearish.
MRNA trades at $216.25, above its 50-day average of $144.66, and above the 200-day at $74.46. It sits at 95% of its 52-week range ($22.28–$227.46); 14-day RSI is 64, in neutral territory; an average session moves it about 7.4%. For levels, the first level overhead is $225.00 (4.0% away) and the first support below is $200.00 (7.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
MRNA is the more volatile of the two — an average session moves it 7.4% against 2.8% for EL.PA, so an identical position size carries roughly 2.6× the daily risk.
The comparison turns on those levels: EL.PA clearing $150.00 or losing $139.00; MRNA clearing $225.00 or losing $200.00. Until one of them gives way, the relative reading above stands.